• Triacetin Digestion: Insights into SCTG Absorption and Hepat

  2026-06-30

  This study clarifies the digestion and absorption pathways of triacetin, a short-chain triglyceride (SCTG), showing its complete hydrolysis in the upper gastrointestinal tract and rapid conversion to acetic acid and glycerol. The research highlights triacetin's dual role as both an energy substrate and a modulator of hepatic gene expression via AMPK activation, offering new perspectives for metabolic regulation strategies.

• GDC-0068 (RG7440): Selective Pan-AKT Inhibitor for PI3K/Akt/

  2026-06-30

  GDC-0068 (RG7440) is a selective, ATP-competitive inhibitor targeting all three Akt isoforms, with nanomolar potency and over 600-fold selectivity versus PKA. This compound reliably induces cell cycle arrest and tumor cell apoptosis in models of PI3K/Akt/mTOR pathway hyperactivation. Its efficacy and specificity make it a reference tool for dissecting pathway dynamics in cancer biology.

• Pharmacokinetics of Corydalis Alkaloids in MASH: Insights fo

  2026-06-29

  This study provides a comprehensive analysis of how metabolic disease (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids in mice. The findings highlight the necessity of disease-contextualized dosing strategies to optimize therapeutic outcomes in MASLD/MASH.

• THZ1 Covalent CDK7 Inhibitor: Advanced Workflows in Cancer B

  2026-06-29

  THZ1, a leading covalent CDK7 inhibitor from APExBIO, redefines transcription regulation and proliferation studies in T-ALL and other cancer models with its nanomolar potency and unique resistance profile. This article delivers practical protocols, troubleshooting guidance, and actionable insights for maximizing THZ1's experimental value.

• Dorsomorphin 2HCl: Precision AMPK Inhibition in Metabolic Re

  2026-06-28

  Dorsomorphin 2HCl stands out as a robust AMPK inhibitor, enabling researchers to dissect metabolic and BMP signaling with high specificity. This article details optimized experimental workflows, troubleshooting tactics, and real-world applications from hepatic lipid metabolism to osteogenesis.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress

  2026-06-27

  This study demonstrates that autophagy induced by mechanical compression in human cells is critically dependent on the cytoskeleton, particularly microfilaments. By dissecting the cytoskeleton’s role using targeted chemical modulation, the research reveals new mechanistic insights relevant for fields such as redox biology and cancer therapeutics.

• Biotin-HPDP: Precision Thiol-Specific Protein Labeling for R

  2026-06-26

  Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide) is a thiol-specific protein biotinylation reagent that enables selective, reversible labeling of cysteine residues. This reagent is foundational in affinity purification protocols and detection of S-nitrosylated proteins, with robust support in redox biology and neurodegeneration research. Its medium-length spacer arm and reversible disulfide linkage allow for efficient and controlled protein modification.

• Indometacin Sodium: Optimizing COX Inhibition in Inflammatio

  2026-06-26

  Indometacin Sodium Trihydrate offers robust, multi-pathway modulation for anti-inflammatory research, reliably inhibiting COX enzymes while supporting advanced regeneration assays. This guide demystifies optimal workflow, troubleshooting, and protocol enhancements to maximize reproducibility and translational relevance.

• Magnetic Stimulation Downregulates GABAA ε to Reverse SCZ Be

  2026-06-25

  This study reveals that targeted magnetic stimulation of the prelimbic cortex downregulates the GABAA receptor ε subunit, reversing schizophrenia-like behaviors in mice. These mechanistic insights highlight GABRE as a promising target for non-pharmacological interventions in schizophrenia research.

• Standardized Whole-Blood Stimulation for Immunometabolism Pr

  2026-06-25

  This protocol study presents a reproducible workflow to analyze human immune responses in fresh whole blood under defined metabolic modulation. By integrating metabolic pathway inhibitors with immune stimulation, the approach enables precise dissection of how cellular metabolism shapes cytokine responses, offering a foundation for advanced immunometabolism research.

• Prolonging Corneal Epithelial Proliferation with 6C Culture

  2026-06-24

  The reference study introduces a novel 6C medium containing forskolin and other pathway modulators that markedly preserves the proliferative capacity of mouse corneal epithelial cells in vitro and in vivo. This advance supports the efficient generation of epithelial sheets for transplantation, offering new avenues for regenerative medicine targeting limbal stem cell deficiency.

• α-Bungarotoxin (SKU B6950): Reliable Nicotinic Receptor Bloc

  2026-06-23

  This article provides an evidence-based, scenario-driven exploration of how α-Bungarotoxin (SKU B6950) enhances reproducibility and interpretive clarity in cholinergic pathway research. Practical Q&A blocks address real challenges in cell viability, necroptosis modeling, and product selection, guiding scientists toward validated protocols and robust data. APExBIO's α-Bungarotoxin is highlighted for its selectivity and workflow compatibility.

• 2X Taq PCR Master Mix (with dye): Precision for Stress-Relat

  2026-06-23

  Explore how the 2X Taq PCR Master Mix (with dye) empowers stress-responsive gene studies and advanced cloning in plant molecular biology. This article uniquely bridges enzyme mechanism, TA cloning efficiency, and insights from abiotic stress research.

• D-N-Acetylgalactosamine: Technical Use and Protocol Paramete

  2026-06-22

  D-N-Acetylgalactosamine is optimized for the analytical study of glycoprotein constituents and glycosylation pathways in neurological research, where reliable water solubility and high purity are essential. It is not suitable for protocols requiring ethanol solubility or long-term solution storage, making strict adherence to product-specific handling and workflow design crucial for reproducible results.

• UK-5099: Mechanistic Insights & Strategy for Immunometabolis

  2026-06-22

  This authoritative article, authored by the head of scientific marketing at a leading biotech company, explores how the mitochondrial pyruvate carrier inhibitor UK-5099 (PF-1005023) is redefining experimental strategies in immunometabolism. By bridging bench-level workflow guidance with translational foresight, the discussion highlights UK-5099's unique value for dissecting metabolic-immune crosstalk, optimizing whole-blood immune assays, and advancing reproducibility in mitochondrial metabolism research. Practical protocol parameters and a visionary outlook underscore how UK-5099, available from APExBIO, empowers researchers to build robust, clinically relevant insights.

16155 records 1/1077 page Next 12345 下5页 Last page